Saudi Arabia Blood Bags Market to Grow with a CAGR of 5.28% through 2030

Growing Prevalence of Blood-Related Diseases and Expansion of Healthcare Infrastructure under Vision 2030 are the major drivers for the Saudi Arabia Blood Bags market growth in the forecast period, 2026-2030

According to TechSci Research report, “Saudi Arabia Blood Bags Market – By Region, Competition, Forecast & Opportunities, 2030F”, the Saudi Arabia Blood Bags Market stood at USD 11.74 Million in 2024 and is anticipated to grow with a CAGR of 5.28% in the forecast period, 2026-2030.

Saudi Arabia faces a disproportionately high incidence of hereditary and chronic blood-related disorders most notably sickle cell anemia, thalassemia, hemophilia, and leukemia with concentrations varying by region. These conditions necessitate recurrent, and in many cases lifelong, blood transfusions, creating a predictable and inelastic demand for quality-assured blood bag systems. As diagnostic services penetrate previously underserved areas and therapeutic infrastructure becomes more robust, the transfusion-dependent patient population is expected to increase, reinforcing a stable and expanding market base for blood bags particularly multi-compartment systems that facilitate component therapy.

The expanding scope of complex surgical procedures including cardiovascular surgeries, orthopedic reconstruction, and organ transplants is fueling an elevated need for reliable blood supplies. Concurrently, road traffic accidents remain a persistent public health challenge, with Saudi Arabia among the countries with the highest road traffic mortality rates in the Gulf region. These dynamics are intensifying the demand for emergency-ready, sterile blood bag systems, including triple and quadruple blood bags, which enable component separation to optimize transfusion efficiency. As surgical capabilities continue to expand in both public and private hospitals, the market is witnessing a qualitative shift toward higher-value, precision-engineered blood bags.

Through coordinated campaigns led by the Ministry of Health (MoH) and supported by regional health directorates, Saudi Arabia has institutionalized voluntary blood donation as a cornerstone of national healthcare planning. These efforts intensify during high-demand periods such as the Hajj and Umrah seasons, where the risk of emergencies and acute medical cases rises significantly. The government’s increased investment in mobile donation units, awareness platforms, and digital donor registries is reinforcing predictable blood bag consumption cycles, particularly among regional and tertiary care hospitals that rely on continuous replenishment of sterile collection units.

Saudi Arabia is undergoing a strategic transition from whole blood transfusion to component-based therapy, necessitating the adoption of multi-bag systems that can isolate and store red blood cells, plasma, and platelets separately. The deployment of automated blood processing systems and the integration of advanced features such as leukocyte filtration, integrated sample ports, and RFID-enabled traceability mechanisms are rapidly transforming product specifications. This trend is not only raising average revenue per unit (ARPU) in the blood bags segment but is also positioning high-end, innovation-driven suppliers to gain market share in institutional procurement contracts.

The Kingdom’s private healthcare sector driven by liberalization, foreign direct investment, and growing insurance penetration has seen a notable uptick in private hospitals, specialty clinics, and diagnostic labs. These facilities often adopt international accreditation standards, necessitating compliance with rigorous blood handling protocols. Consequently, demand is shifting toward premium-quality blood bags that support efficient, contamination-free storage and transfusion processes. Procurement cycles in the private sector also tend to favor rapid delivery and high service-level agreements, encouraging suppliers to localize inventory and streamline logistics.

Saudi Arabia’s demographic trajectory characterized by rapid population growth and increasing life expectancy is reshaping the healthcare burden. The rise in non-communicable diseases, age-related conditions, and lifestyle disorders is translating into greater transfusion frequency, especially among elderly and chronically ill populations. This is fueling sustained long-term demand for blood collection and storage products, ensuring that the blood bags market remains not only volume-driven but also strategically relevant to national healthcare resilience.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Saudi Arabia Blood Bags Market”

The Saudi Arabia Blood Bags Market is segmented into product type, type, volume, material, end-user, regional distribution, and company.

Based on its end user, the Hospitals & Clinics segment has emerged as the predominant market leader, Hospitals especially large tertiary care institutions and specialty centers conduct most surgeries, trauma interventions, and chronic disease treatments that require blood transfusion. These procedures often involve: Major surgeries such as organ transplants, oncology interventions, and cardiovascular operations. High-risk obstetric and neonatal care requiring immediate transfusion readiness. Management of transfusion-dependent conditions like thalassemia, leukemia, and sickle cell disease. As such, hospitals consume a broad spectrum of blood bag types, particularly triple and quadruple bags for component separation, and drive high-frequency procurement cycles based on predictable usage.

Saudi Arabia’s Vision 2030 reforms have significantly boosted investments in hospital infrastructure, both public and private. Mega health clusters such as: King Fahad Medical City, King Faisal Specialist Hospital & Research Centre, Ministry of National Guard Health Affairs, leading private chains like Dr. Sulaiman Al Habib and Al Hammadi Hospitals are expanding bed capacity, introducing specialized transfusion medicine departments, and complying with international transfusion protocols thereby increasing demand for premium, sterile, and traceable blood bags. Given Saudi Arabia’s high incidence of road traffic injuries, workplace accidents, and seasonal mass gatherings (e.g., Hajj and Umrah), hospitals are required to maintain strategic reserves of blood and blood components. Bulk procurement of blood bags for emergency storage. Demand for validated, sterile, and leak-proof products that support prolonged shelf life and compatibility with automated systems. Close coordination with blood banks and mobile donation units that primarily serve hospital-based transfusion units.

Major companies operating in Saudi Arabia Blood Bags Market are:

• Terumo Middle East
• Fresenius Kabi
• Madac International for Medical Products Factory
• RENOLIT
• Abdulla Fouad Group
• Kiefel Technologies
• AdvaCare Pharma
• Jamjoom Group.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The Saudi Arabia blood bags market is poised for sustained growth, underpinned by structural healthcare reforms, a rising burden of transfusion-dependent conditions, and increasing demand from both public and private medical institutions. As the Kingdom advances its Vision 2030 objectives focusing on healthcare modernization, digital transformation, and local manufacturing the market offers attractive opportunities for manufacturers, distributors, and investors seeking to align with evolving clinical needs and regulatory standards. Strategic investments in innovation, compliance, and supply chain integration will be essential to capture market share and support the delivery of high-quality, safe, and efficient transfusion solutions across the Kingdom.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Saudi Arabia Blood Bags Market, By Product Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag), By Type (Collection Bag, Transfer Bag), By Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml), By Material (PVC, PET, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centre, Blood Banks, Others) By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of Saudi Arabia Blood Bags Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Saudi Arabia Blood Bags Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com